фармакология и фармация

1241 проекта

H2020Индивидуална стипендия2021–2024Германия

FULLREMOVAL · Feasibility of ULtrafiLtration membranes for REMOVAL of antibiotic resistant bacteria and antibiotic resistance genes from secondary effluents from wastewater treatment plants

H2020Обмен на изследователи2021–2025Германия

MYCOBIOMICS · Joining forces to exploit the mycobiota of Asia, Africa and Europe for beneficial metabolites and potential biocontrol agents, using -OMICS techniques

8 партньори · 7 държави

H2020Обмен на изследователи2021–2026Украйна

ALISE · Anti-Cancer Light-Controllable Antibody-Peptide Conjugates

6 партньори · 4 държави

H2020Обмен на изследователи2021–2026Италия

SusWater · Sustainable integrated approach to achieve CECs and PTEs removal from contaminated waters. The aquaculture as case study

9 партньори · 6 държави

H2020Обмен на изследователи2021–2025Словакия

SAFEMILK · Innovative technology for milk safety

12 партньори · 6 държави

H2020Докторантска мрежа2021–2024Дания

PEST-BIN · Pioneering Strategies Against Bacterial Infections

11 партньори · 7 държави

H2020Докторантска мрежа2021–2025Германия

CC-TOP · C-C Bond Formation Using Top Performing Enzymes

12 партньори · 6 държави

H2020Докторантска мрежа2021–2025Дания

INNOTARGETS · Innvative approaches to identification of metabolic Targets for antimicrobials

9 партньори · 6 държави

H2020Докторантска мрежа2021–2025Италия

NanED · Electron Nanocrystallography

8 партньори · 7 държави

H2020Докторантска мрежа2021–2024Гърция

AGePOP · Drug Absorption in Geriatric Patients and Older People: a training network innovating drug development for the advanced age population

6 партньори · 4 държави

H2020Индивидуална стипендия2021–2023Франция

PORTable STaNDOuTs · Perfused Organs-on-a-Chip integrated with TEER measurement technique: A novel approach towards studying non-targeted drug induced organ toxicity

H2020Индивидуална стипендия2021–2023Германия

EvoSpa · Structured, not stirred: experimental evolution in programmable antibiotic landscapes

H2020Докторантска мрежа2021–2025Италия

REMEDI · Trapping and Removal of X-ray Contrast Medium agents from water resource and stream Sediments- New Concepts in Trapping, Recycling and Management

3 партньори · 3 държави

H2020Индивидуална стипендия2021–2022Дания

SlowDisasters · Political Dynamics of Slow-Onset Disasters: Contrasting Antimicrobial Resistance (AMR) and Ebola Responses

H2020Индивидуална стипендия2021–2023Обединеното кралство

G4-AntiBac · Targeting G-quadruplex DNA Structures in Bacteria to Combat Antimicrobial Resistance

H2020Индивидуална стипендия2021–2023Обединеното кралство

CAGECONTROL · Identification and manipulation of factors that control Shigella flexneri entrapment in septin cages.

H2020Индивидуална стипендия2021–2023Обединеното кралство

IDYEA · Antimicrobial resistance in engineered wastewater systems – Predicting the impacts of dynamic exposure levels to antimicrobial agents on AMR attenuation and amplification

H2020Индивидуална стипендия2021–2022Германия

NERS · Novel Electro-Responsive Protein Separation Method with Magnetic Nanoparticles

2 партньори · 2 държави

H2020Индивидуална стипендия2021–2023Испания

THERMUCNA · Thermoresponsive and mucoadhesive nanogels for intramammary administration of antimicrobial compounds to be employed in bovine mastitis treatment

H2020Индивидуална стипендия2021–2023Италия

FLAMMES · On-chip metasurface-based neuroimaging platform toward high-throughput drug screening in freely behaving animal

H2020Индивидуална стипендия2021–2023Обединеното кралство

PSIPCancer · Role of PSIP1 in prostate cancer development and drug resistance

H2020Индивидуална стипендия2021–2023Швейцария

GOOD OR BAD BUGS · GOOD OR BAD BUGS, FRIEND OR FOES: UNRAVELING DIFFERENCES BETWEEN MUTUALISM AND PATHOGENICITY IN BURKHOLDERIA SPECIES

H2020Индивидуална стипендия2021–2024Франция

MITHAML · Exploring the role of Metabolic IntraTumoral Heterogeneity in drug resistance of Acute Myeloid Leukemia in vivo

2 партньори · 2 държави

H2020Индивидуална стипендия2021–2024Германия

Tumour T cells · The fate and therapeutic potential of human neoantigen-specific T cells